Clinical trial at InVia Fertility lowers cost of IVF

[April 24, 2015: This clinical trial is no longer open.] 

Patients with infertility that require in vitro fertilization (IVF) now have an opportunity to enroll in a clinical trial that lowers the cost of IVF.

Enrollment has begun for a research study (A Phase III Study to Compare Efficacy and Safety of AFOLIA vs. Gonal-F in Infertile Women 35 to 42 Years of Age Undergoing in Vitro Fertilization (IVF) (FIN3002)), which aims to examine the efficacy of a generic form of ovarian stimulation medication for IVF.

 Patients who qualify for this study will be eligible to undergo up to three IVF cycles for a fraction of the regular price, and will receive the majority of their medication at no cost, dramatically lowering the cost of IVF at our Chicago-area clinics. The study is sponsored by Finox Pharmaceuticals, a Swiss biotech company focused on fertility products. The generic medication that will be used in the study has already been approved in Europe.

Patient Inclusion and Exclusion Criteria

Inclusion criteria

• Age 35 – 42 y
• Regular menstrual cycles
• BMI between 18 and 38
• Normal Pap smear
• Presence of both ovaries

Exclusion criteria

• Polycystic ovary syndrome (PCOS)
• > 2 previous failed IVF cycles
• Fibroids > 5 cm
• History of 3 or more spontaneous abortions
• History of medical disease requiring regular treatment (e.g. diabetes, epilepsy, hypertension)

Cost of IVF: out-of-pocket expenses

Cycle 1 — $2,000

Cycle 2 — $3,000

Cycle 3 – $3,000

This includes most medications, cycle monitoring, egg retrieval, anesthesia and embryo transfer.

It does not include the following:

• Initial consultation and work up
• Cryopreservation of extra embryos ($1,000) + $50/month storage fee
• Crinone gel after the first positive pregnancy test.